title: Metabolic syndrome in the rural population of wardha, central India: an exploratory factor analysis.
abstract: OBJECTIVE
  Metabolic syndrome - a plausible precondition for type II diabetes and cardiovascular diseases is also on rise. To understand the mechanistic complexity of metabolic syndrome it is imperative to study the specific contribution of the determinants of metabolic syndrome. Such study can help to identify the most significant factor which may be of use in early detection as well as prevention efforts. Such information is scarcely available from India and especially from rural India. Hence, the present study was undertaken to explore for such factor which might be considered crucial for development of such pathogenesis particularly in rural population of Wardha.
  
  
  METHODS
  A cross-sectional study comprising of 300 subjects was carried out in rural area of Primary Health Center, attached to medical college with approximate 31,000 populations. The anthropometric parameters such as height, weight, waist circumference were measured. Overnight fasting samples were collected for lipid profile (total cholesterol, triglyceride, high density lipoproteins, low density lipoproteins, very low density lipoproteins) and fasting blood glucose levels. The National Cholesterol Education Programme Adult Treatment Panel, ATP-III guidelines were used to categorize the study subjects. As many of the variables are highly intercorrelated, exploratory factor analysis was carried out to reduce the data to a smaller number of independent factors that accounts for the most of the variances in the data. Principal component analysis was used as a method of extraction.
  
  
  RESULTS
  For both sexes, three factors were extracted accounting for about 71% variance in the measured variables. An adiposity factor which accounted for highest explained variance (28%), was the initial factor extracted. It was loaded positively by waist circumference, triglyceride, and very low density lipoprotein and negatively loaded by high density lipoprotein. Second factor extracted was a cholesterol factor which explained about 20% variance. It was positively loaded by total cholesterol and low density lipoprotein. Blood pressure factor was third to be extracted which again explained about 20% variance. It was positively loaded by systolic and diastolic blood pressure.
  
  
  CONCLUSIONS
  The results clearly indicate the significance of visceral adiposity over the obesity in general or simple abdominal obesity measured anthropometrically as a pathogenic determinant of the metabolic syndrome. The most consistent factor has been found to be dyslipidemia which explained major share of the observed variance and the most significant load of this factor being rested on triglyceride and the VLDL level. Hence, we conclude measurement of triglyceride might be a rewarding screening parameter for assessment of cardio-metabolic risk in general populace and warrants a large scale study focusing into this issue.
authors.affiliation: Department of Community Medicine, Mahatma Gandhi Institute of Medical Sciences, Sewagram, India.
authors.forename: Pradeep R
authors.initials: PR
authors.lastname: Deshmukh
authors.forename: Pranita
authors.initials: P
authors.lastname: Kamble
authors.forename: Kalyan
authors.initials: K
authors.lastname: Goswami
authors.forename: Neelam
authors.initials: N
authors.lastname: Garg
keywords: ATP-III; CVD; Metabolic syndrome; diabetes; dyslipidemia; factor analysis
references.citation: J Clin Invest. 2005 May;115(5):1298-305
references.pmid: 15864349
references.citation: Circulation. 2004 Sep 7;110(10):1245-50
references.pmid: 15326067
references.citation: Diabetes Care. 2003 Aug;26(8):2341-4
references.pmid: 12882859
references.citation: Indian Heart J. 1996 May-Jun;48(3):241-5
references.pmid: 8755007
references.citation: Arch Intern Med. 2004 May 24;164(10):1066-76
references.pmid: 15159263
references.citation: Cell. 1999 Oct 29;99(3):239-42
references.pmid: 10555139
references.citation: Indian J Med Res. 2006 May;123(5):679-86
references.pmid: 16873911
references.citation: Clin Chem. 1974 Apr;20(4):470-5
references.pmid: 4818200
references.citation: Diabetologia. 2007 Nov;50(11):2356-65
references.pmid: 17849096
references.citation: Arch Intern Med. 1997 Nov 24;157(21):2413-46
references.pmid: 9385294
references.citation: J Assoc Physicians India. 2003 Aug;51:771-7
references.pmid: 14651136
references.citation: Nature. 2006 Dec 14;444(7121):881-7
references.pmid: 17167477
references.citation: N Engl J Med. 2007 Jan 18;356(3):213-5
references.pmid: 17229948
references.citation: Hypertension. 2005 Mar;45(3):363-7
references.pmid: 15668356
references.citation: Diabetes Metab. 2004 Feb;30(1):7-12
references.pmid: 15029092
references.citation: Clin Chem. 1972 Jun;18(6):499-502
references.pmid: 4337382
references.citation: Hypertension. 2005 Aug;46(2):326-32
references.pmid: 16027245
references.citation: Circulation. 2004 Jan 27;109(3):433-8
references.pmid: 14744958
references.citation: J Endocrinol Invest. 2006;29(3 Suppl):77-82
references.pmid: 16751711
references.citation: Hypertension. 2009 Apr;53(4):577-84
references.pmid: 19237685
references.citation: Diabetes. 2002 Oct;51(10):3120-7
references.pmid: 12351457
references.citation: Am J Physiol Regul Integr Comp Physiol. 2004 Jul;287(1):R112-9
references.pmid: 15001430
references.citation: J Lipid Res. 1970 Nov;11(6):583-95
references.pmid: 4100998
references.citation: JAMA. 2001 May 16;285(19):2486-97
references.pmid: 11368702
references.citation: J Atheroscler Thromb. 1996;3(2):81-9
references.pmid: 9226459
references.citation: Am J Physiol. 1997 Jul;273(1 Pt 2):R236-42
references.pmid: 9249555
references.citation: Circulation. 2003 Jul 29;108(4):414-9
references.pmid: 12860911
references.citation: Diabetes. 2003 May;52(5):1210-4
references.pmid: 12716754
references.citation: J Clin Invest. 2004 Dec;114(12):1752-61
references.pmid: 15599400
references.citation: Indian J Med Res. 2002 Oct;116:121-32
references.pmid: 12674825